GIANT AXONAL NEUROPATHY

Clinical trials for GIANT AXONAL NEUROPATHY explained in plain language.

Never miss a new study

Get alerted when new GIANT AXONAL NEUROPATHY trials appear

Sign up with your email to follow new studies for GIANT AXONAL NEUROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

First human trial offers hope for rare, fatal nerve disease

Disease control Ongoing

This is a first-in-human safety study testing a new gene therapy for Giant Axonal Neuropathy (GAN), a rare and fatal genetic disorder that damages nerves. Researchers are giving a single spinal injection that delivers a working copy of the faulty gene to the brain and spinal cord…

Matched conditions: GIANT AXONAL NEUROPATHY

Phase: PHASE1 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control

Last updated Mar 25, 2026 14:07 UTC

GIANT AXONAL NEUROPATHY

Get alerted when new GIANT AXONAL NEUROPATHY trials appear

First human trial offers hope for rare, fatal nerve disease